Skip to main content

Table 1 The association between SLC2A3 mRNA levels and the clinicopathological parameters in 44 GC patients included in the OS analysis

From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer

Clinicopathological parameters

SLC2A3 expression

p-value

Low

High

Age

 < 60

8

13

p = 0.533

 ≥ 60

8

15

 

Gender

 Male

12

18

p = 0.350

 Female

4

10

 

pStage

 I

5

2

p = 0.049

 II–IV

11

26

 

pT grade

 T1, 2

7

4

p = 0.037

 T3, 4

9

24

 

pN grade

 N0

9

10

p = 0.157

 N1–3

7

18

 

pM grade

 M0

16

26

p = 0.400

 M1

0

2

 

Total

16

28

 
  1. SLC2A3 protein expression was significantly higher in patients with pathological stage (p = 0.049) and advanced T (p = 0.037) but showed no association with age, gender, N and M grades
  2. GC Gastric cancer, OS overall survival, TNM tumor, N lymph node, M metastasis